Blood platelets and myocardial infarction: Do hyperactive platelets really exist?

Transfusion Medicine and Hemotherapy

Volumn 33, Issue 2, 2006, Pages 189-199

  Scharf, Rüdiger E ^a   Zotz, Rainer B ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

Arterial thrombogenesis; Human platelet antigens (HPA); Myocardial infarction; Platelet receptor polymorphisms; Platelet thrombogenicity

Indexed keywords

ALPHA2 807TT PROTEIN; ALPHA2 INTEGRIN; ALPHA2B BETA3 INTEGRIN; BETA1 INTEGRIN; FIBRINOGEN RECEPTOR; HUMAN PLATELET ANTIGEN 1; HUMAN PLATELET ANTIGEN 1B; HUMAN PLATELET ANTIGEN 5; INTEGRIN; INTEGRIN RECEPTOR; MUTANT PROTEIN; PROTEIN; THROMBOCYTE ANTIGEN; THROMBOCYTE RECEPTOR; UNCLASSIFIED DRUG; VERY LATE ACTIVATION ANTIGEN 2;

ARTERY BLOOD FLOW; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL ACTIVITY; CHROMOSOME; CLINICAL STUDY; CONFERENCE PAPER; CORONARY ARTERY DISEASE; DNA POLYMORPHISM; DNA SEQUENCE; GENE; GENETIC TRANSFECTION; GENETIC VARIABILITY; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; HEART INFARCTION; HUMAN; PATHOGENESIS; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PHENOTYPE; PROSPECTIVE STUDY; THROMBOCYTE; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; THROMBOCYTOPENIA; THROMBOGENESIS; THROMBOGENICITY;

EID: 33645658363     PISSN: 16603796     EISSN: None     Source Type: Journal    
DOI: 10.1159/000091458     Document Type: Conference Paper

References (46)

1. Fitzgerald DJ, Roy L, Catella F, FitzGerald GA: Platelet activation in unstable coronary disease. N Engl J Med 1986;315:983-989.
2. Scharf RE: Thrombozyten und Mikrozirkulationsstörungen. Stuttgart, New York, Schattauer, 1986.
3. Fuster V, Badimon L, Badimon JJ, Chesbro JH: The pathogenesis of coronary artery disease and the acute coronary syndromes (1). N Engl J Med 1992;326:242-250.
4. Scharf RE, Tomer A, Marzec UM, Teirstein PS, Ruggeri ZM, Harker LA: Activation of platelets in blood perfusing angioplasty-damaged coronary arteries. Flow cytometric detection. Arterioscler Thromb Vase Biol 1992;12:1475-1487.
5. Hannington E, Jones RJ, Amess JAL, Wachowicz B: Migraine: a platelet disorder. Lancet 1981;ii:720.
6. Davies JA, McNicol GP: Detection of a prethrombotic state; in Bloom AL, Thomas DP (eds): Haemostasis and Thrombosis. Edinburgh, London, Churchill Livingstone, 1981, pp 593-609.
7. Yee DL, Sun CW, Bergeron AL, Dong JF, Bray PF: Aggregometry detects platelet hyperreactivity in healthy individuals. Blood 2005;106:2723-2729.
8. Trip MD, Cats VM, van Capelle FJL, Vreeken J: Platelet hyperreactivity and prognosis in survivors of myocardial infarction. N Engl J Med 1990;322:1549-1554.
9. Mammen EF: Sticky platelet syndrome. Semin Thromb Hemost 1999;25:361-365.
10. Scharf RE: Molecular basis and clinical aspects of hereditary megakaryocyte and platelet membrane glycoprotein disorders. Hämostaseologie 1996;16:114-138.
11. Kunicki TJ, Newman PJ: The molecular immunology of human platelet proteins. Blood 1992;80:1386-1404.
12. A2, are associated with a leucine 33/proline 33 amino acid polymorphism in membrane GPIIIa, and are distinguishable by DNA typing. J Clin Invest 1989;83:1778-1781.
13. Nieswandt B, Watson SP: Platelet-collagen interaction: is GPVI the central receptor? Blood 2003;102:449-461.
14. 1 play independent critical roles during platelet adhesion and aggregate formation to collagen under flow. Blood 2005;106:1268-1277.
15. Kunicki TJ, Kritzik M, Annis DS, Nugent DJ: Hereditary variation in platelet alpha2 beta1 density is associated with two silent polymorphisms in the alpha2 coding sequence. Blood 1997;89:1939-1943.
16. Kritzik M, Savage B, Nugent DJ, Santoso S, Ruggeri ZM; Kunicki TJ: Nucleotide polymorphisms in the alpha2 gene define multiple alleles that are associated with differences in platelet alpha2 beta1 density. Blood 1998;92:2382-2388.
17. Weiss EJ, Bray PF, Tayback M, Shulman SP, Kickler TS, Becker LC, Weiss JL, Gerstenblith G, Goldschmidt-Clermont PJ: A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. N Engl J Med 1996;334:1090-1094.
18. A1/A2 polymorphism of platelet glycoprotein IIIa and the risks of myocardial infarction, stroke, and venous thrombosis. Lancet 1997;349:385-388.
19. A1/A2 polymorphism with myocardial infarction. Am J Cardiol 2000;86:1000-1005.
20. A1/A2 and coronary risk: a meta-analysis. Thromb Haemost 2001;85:626-633.
21. Zotz RB, Scharf RE: Platelet receptor polymorphisms and their role in cardiovascular disease. J Lab Med 2002;26:584-593.
22. Moshfegh F, Wuillemin WA, Redondo M, Lämmle B, Beer JH, Liechti-Gallati S, Meyer BJ: Association of two silent polymorphisms of platelet glycoprotein Ia-IIa receptor with risk of myocardial infarction: a case-control study. Lancet 1999;353:351-354.
23. Santoso S, Kunicki TJ, Kroll H, Haberbosch W, Gardemann A: Associations of the platelet glycoprotein Ia C807T gene polymorphism with nonfatal myocardial infarction in younger patients. Blood 1999;93:2449-2453.
24. A2) is an inherited risk factor for premature myocardial infarction in coronary artery disease. Thromb Haemost 1998;79:731-735.
25. A2) is an inherited risk factor for bypass occlusion, myocardial infarction, and death. Thromb Haemost 2000;81:404-407.
26. Bray PE: Platelet glycoprotein polymorphisms as risk factors for thrombosis. Curr Opin Hematol 2000;7:284-289.
27. 1 (α2807TT) with premature myocardial infarction. J Thromb Haemost 2005;3: 1522-1529.
28. Scharf RE, Deitenbeck R, Giers G, Zotz RB: Increased binding of soluble fibrinogen to the platelet glycoprotein IIb-IIIa receptor related to the polymorphism of the GPIIIa gene (HPA-1b/PlA2). Blood 1997;90:256a.
29. b) positive platelets in patients with cardiovascular disease. Eur Heart J 1999;20:742-747.
30. Bennett JS, Catella-Lawson F, Rut AR, Vilaire G, Qi W, Kapoor SC, Murphy S, FitzGerald GA: Effect of the PlA2 alloantigen on the function of β3-integrins in platelets. Blood 2001;97:3093-3099.
31. A2 polymorphism: the Framinham Offspring Study. Arterioscler Thromb Vasc Biol 1999;19:1142-1147.
32. Feng D, Lindpaintner K, Larson MG, O'Donnell CJ, Lipinska I, Sutherland PA, Mittleman M, Muller JE, D'Agostino RB, Levy D, Tofler GH: Platelet glycoprotein IIIa Pl(A) polymorphism, fibrinogen, and platelet aggregability: The Framingham Heart Study. Circulation 2001;104:140-144.
33. A polymorphisms display different sensitivities to agonists. Circulation 2000;101:1013-1018.
34. 3 on its surface expression and platelet secretion (submitted).
35. Weber AA, Jacobs, Meila D, Weber S, Zotz RB, Scharf RE, Kelm M, Strauer BE, Schrör K: No evidence for an influence of the human platelet antigen-1 polymorphism on the antiplatelet effects of glycoprotein IIb-IIIa inhibitors. Pharmacogenetics 2002;12:581-583.
36. Savage B, Saldivar E, Ruggeri ZM: Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell 1996;84:289-297
37. Savage B, Almus-Jacobs F, Ruggeri ZM: Specific synergy of multiple substrate-receptor interactions in platelet thrombus formation under flow. Cell 1998;94:657-666.
38. Ruggeri ZM: Von Willebrand factor, platelets and endothelial cell interactions. J Thromb Haemost 2003;1:1335-1342.
39. Stoldt VR, Peveling J, Loncar R, Beck A, Aurich V, Scharf RE: Evaluation of platelet thrombus formation under flow. Blood 2005;106:3954.
40. A2 polymorphism of integrin β3 enhances outside-in signaling and adhesive functions. J Clin Invest 2000;105:793-802.
41. Vijayan KV, Huang TC, Liu Y, Bernardo A, Dong JF, Goldschmidt-Clermont PJ, Alevriadou BR, Bray PF: Shear stress augments the enhanced adhesive phenotype of cells expressing the Pro33 isoform of integrin β3. FEES Lett 2003;540:41-46.
42. Vijayan KV, Liu Y, Sun W, Ito M, Bray PF: The Pro33 isoform of integrin beta3 enhances outside-in signaling in human platelets by regulating the activation of serine/threonine phosphatases. J Biol Chem 2005;280:21756-21762.
43. Bray PF: Integrin polymorphisms as risk factors for thrombosis. Thromb Haemost 1999;82:337-344.
44. Williams MS, Bray PF: Genetics of arterial prothrombotic risk states. Exp Biol Med 2001;226:409-419.
45. Lane DA, Grant PJ: Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease. Blood 2000;95:1517-1532.
46. Mikkelsson J, Perola M, Laippala P, Savolainen V, Pajarinen J, Lalu K, Penttilä A, Karhunen PJ: Glycoprotein IIIa polymorphism associates with progression of coronary artery disease and with myocardial infarction in an autopsy series of middleaged men who died suddenly. Arterioscler Thromb Vase Biol 1999;19:2573-2578.